Regulatory Effects of Histone Deacetylase Inhibitors on Myeloid-Derived Suppressor Cells

Histone deacetylase inhibitors (HDACIs) are antitumor drugs that are being developed for use in clinical settings. HDACIs enhance histone or nonhistone acetylation and promote gene transcription via epigenetic regulation. Importantly, these drugs have cytotoxic or cytostatic properties and can direc...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Yudan, Cai, Jingshan, Wang, Wenxin, Wang, Shengjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208029/
https://www.ncbi.nlm.nih.gov/pubmed/34149732
http://dx.doi.org/10.3389/fimmu.2021.690207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208029/
https://www.ncbi.nlm.nih.gov/pubmed/34149732
http://dx.doi.org/10.3389/fimmu.2021.690207

Ejemplares similares